Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript July 30, 2024

Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.16.

Operator: Good day and thank you for standing by and welcome to Nautilus Q2 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today to Ji-Yon Yi, Investor Relations....